PPARA and hyperlipidemia: Derivatives of N-acetyl-L-tyrosine were shown to have binding affinity to the peroxisome proliferator-activated receptor alpha (PPARα) at 50 μM (9.1 μg/mL), which is a regulator of lipid homeostasis, and PPARα agonists are described to decrease hyperlipidemia [33].